This inventor holds 1 USPTO granted patent. Top assignees: Institut Organicheskoi Khimii Akademii Nauk Ukrainskoi Ssr, Kievsky Nauchno-Issledovatelsky Institut Otolaringologii. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: Jury P Kovtun: Innovator in Pharmaceutical Chemistry
Introduction
Jury P Kovtun is a notable inventor based in Kyiv, Ukraine. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on novel compounds with potential therapeutic applications. His research focuses on the development of compounds that exhibit immunomodulating, antibacterial, and antiviral activities.
Latest Patents
Jury P Kovtun holds a patent for a unique class of compounds known as 6-Phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]-thiazole derivatives. This patent includes compounds with the general formula: ##STR1## wherein R is CH₂ COOCH₃, CH₂ COOC₁₀ H₂₁, CH₂ CONH₂, and X is Br. These compounds are recognized for their promising biological activities, which could lead to advancements in medical treatments.
Career Highlights
Throughout his career, Jury P Kovtun has worked with esteemed institutions such as the Institute of Organic Chemistry of the Academy of Sciences of the Ukrainian SSR and the Kyiv Scientific Research Institute of Otolaryngology. His work in these organizations has allowed him to explore various aspects of organic chemistry and its applications in medicine.
Collaborations
Jury P Kovtun has collaborated with several professionals in his field, including Eduard V Gjulling and Larisa A Djugovskaya. These collaborations have contributed to the advancement of research and development in pharmaceutical chemistry.
Conclusion
Jury P Kovtun's innovative work in the development of novel pharmaceutical compounds highlights his significant contributions to the field of chemistry. His patent for 6-Phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]-thiazole derivatives showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile